Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: Results of the PANCOSTABRAX study

  1. Carrato, A.
  2. García, P.
  3. Lopez, R.
  4. Macarulla, T.
  5. Rivera, F.
  6. Sastre, J.
  7. Gostkorzewicz, J.
  8. Benedit, P.
  9. Perez-Alcántara, F.
Zeitschrift:
Expert Review of Pharmacoeconomics and Outcomes Research

ISSN: 1744-8379,  1473-7167

Datum der Publikation: 2015

Ausgabe: 15

Nummer: 4

Seiten: 579-589

Art: Rezension

DOI: 10.1586/14737167.2015.1047349 GOOGLE SCHOLAR
Datenquelle: Scopus